CRISPR
CRISPR and crRNAs
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Qing Zhao1, Linxin Wei1, Youxin Chen1
1Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China; Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Beijing 100730, China; Beijing Key Laboratory of Fundus Diseases Intelligent Diagnosis & Drug/Device Development and Translation, Beijing 100730, China.
集群定期间隔的简短巴林德罗姆重复 (CRISPR) /与CRISPR相关的蛋白质 (Cas) 基因编辑显示出治疗危及视力的疾病的前景. 目前正在进行的临床试验和未来的研究旨在克服安全有效的眼疗法所面临的挑战.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: